lactic acid has been researched along with lipid a in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (11.11) | 18.7374 |
| 1990's | 1 (5.56) | 18.2507 |
| 2000's | 9 (50.00) | 29.6817 |
| 2010's | 6 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Astiz, ME; Kim, YB; Rackow, EC; Weil, MH | 2 |
| Bagby, GJ; Lang, CH; Nowotny, A; Spitzer, JJ | 1 |
| Goto, M; Muraskas, J; Myers, TF; Wy, CA; Young, RI | 1 |
| Bahlmann, L; Gliemroth, J; Heringlake, M; Klaus, S; Schmucker, P; Staubach, KH | 1 |
| Diwan, M; Elamanchili, P; Gainer, A; Lane, H; Samuel, J | 1 |
| Chesko, J; Kazzaz, J; O'Hagan, DT; Singh, M; Soenawan, E; Ugozzoli, M | 1 |
| Kwon, GS; Lutsiak, ME; Samuel, J | 1 |
| Alshamsan, A; Elamanchili, P; Hamdy, S; Molavi, O; Samuel, J; Satou, T | 1 |
| Haddadi, A; Hamdy, S; Ruan, D; Samuel, J; Somayaji, V | 1 |
| Alshamsan, A; Elhasi, S; Gobti, Z; Haddadi, A; Hamdy, S; Lavasanifar, A; Ma, Z; Molavi, O; Samuel, J | 1 |
| Hamdy, S; Lavasanifar, A; Ma, Z; Molavi, O; Samuel, J | 1 |
| Bernkop-Schnürch, A; Hintzen, F; Kammona, O; Karageorgiou, V; Kiparissides, C; Kotti, K; Perera, G; Sarti, F | 1 |
| Bershteyn, A; Crespo, MP; Hanson, MC; Irvine, DJ; Li, AV; Moon, JJ; Suh, H | 1 |
| Bobbala, S; Hook, S; McDowell, A | 1 |
| Ahmed, KK; Geary, SM; Salem, AK | 1 |
| Cardieri, MC; Eren, M; Guldner, D; Hwang, JK; Norton, MG; Souza, CD; Ziaei, P | 1 |
| Haddadi, A; Jahan, ST; Sadat, SM | 1 |
18 other study(ies) available for lactic acid and lipid a
| Article | Year |
|---|---|
Monophosphoryl lipid A induces tolerance to the lethal hemodynamic effects of endotoxemia.
Topics: Animals; Cardiac Output; Hemodynamics; Lactates; Lactic Acid; Lipid A; Lipopolysaccharides; Oxygen; Rats; Rats, Inbred Strains; Salmonella; Shock, Septic | 1991 |
Monophosphoryl lipid A blocks the hemodynamic effects of lethal endotoxemia.
Topics: Animals; Endotoxins; Hemodynamics; Lactates; Lactic Acid; Lipid A; Lipopolysaccharides; Pyruvates; Pyruvic Acid; Rats; Rats, Inbred Strains | 1989 |
Effects of toxic and nontoxic endotoxin derivatives on glucose kinetics.
Topics: Animals; Blood Glucose; Blood Pressure; Body Temperature; Cell Wall; Dose-Response Relationship, Drug; Endotoxins; Glucose; Heart Rate; Kinetics; Lactates; Lactic Acid; Lipid A; Male; Metabolic Clearance Rate; Polysaccharides, Bacterial; Rats; Rats, Inbred Strains | 1985 |
Prophylactic treatment of endotoxic shock with monophosphoryl lipid A in newborn rats.
Topics: Adjuvants, Immunologic; Animals; Animals, Newborn; Endotoxins; Female; Fetal Blood; Interleukin-10; Lactic Acid; Lipid A; Maternal-Fetal Exchange; Pregnancy; Preventive Medicine; Rats; Rats, Sprague-Dawley; Shock, Septic; Tumor Necrosis Factor-alpha | 2000 |
Tissue metabolism during endotoxin shock after pretreatment with monophosphoryl lipid A.
Topics: Animals; Endotoxins; Female; Glycerol; Lactic Acid; Lipid A; Liver; Microdialysis; Muscle, Skeletal; Shock, Septic; Subcutaneous Tissue; Swine; Time Factors | 2003 |
Biodegradable nanoparticle mediated antigen delivery to human cord blood derived dendritic cells for induction of primary T cell responses.
Topics: Cancer Vaccines; Dendritic Cells; Drug Carriers; Fetal Blood; Humans; In Vitro Techniques; Lactic Acid; Lipid A; Mucin-1; Nanotechnology; Oligodeoxyribonucleotides; Peptide Fragments; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; T-Lymphocytes; Tetanus Toxoid | 2003 |
Encapsulation of the immune potentiators MPL and RC529 in PLG microparticles enhances their potency.
Topics: Adjuvants, Immunologic; Animals; Chemistry, Pharmaceutical; CHO Cells; Cricetinae; Cricetulus; Lactic Acid; Lipid A; Mice; Microbial Sensitivity Tests; Microspheres; Neisseria meningitidis; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers | 2006 |
Biodegradable nanoparticle delivery of a Th2-biased peptide for induction of Th1 immune responses.
Topics: Amino Acid Sequence; Animals; Female; Hepatitis B Core Antigens; Immunization; Interferon-gamma; Lactic Acid; Lipid A; Lymphocyte Activation; Mice; Mice, Inbred C57BL; Molecular Sequence Data; Nanostructures; Peptide Fragments; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; T-Lymphocytes; Th1 Cells; Th2 Cells | 2006 |
Enhanced antigen-specific primary CD4+ and CD8+ responses by codelivery of ovalbumin and toll-like receptor ligand monophosphoryl lipid A in poly(D,L-lactic-co-glycolic acid) nanoparticles.
Topics: Animals; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cell Proliferation; Clone Cells; Cytokines; Epitopes; Glycolates; Injections, Intraperitoneal; Injections, Subcutaneous; Kinetics; Lactic Acid; Lipid A; Lymph Nodes; Lymphocyte Activation; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Nanoparticles; Ovalbumin; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Solubility; Toll-Like Receptors; Vaccination | 2007 |
Pharmaceutical analysis of synthetic lipid A-based vaccine adjuvants in poly (D,L-lactic-co-glycolic acid) nanoparticle formulations.
Topics: Adjuvants, Immunologic; Animals; B7-2 Antigen; Bone Marrow Cells; CD40 Antigens; Chemistry, Pharmaceutical; Chromatography, Liquid; Cytokines; Dendritic Cells; Drug Compounding; Flow Cytometry; Lactic Acid; Lipid A; Mass Spectrometry; Mice; Mice, Inbred C57BL; Nanoparticles; Phenotype; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Propylene Glycols; Reference Standards; Reproducibility of Results; Solutions; Up-Regulation | 2007 |
Co-delivery of cancer-associated antigen and Toll-like receptor 4 ligand in PLGA nanoparticles induces potent CD8+ T cell-mediated anti-tumor immunity.
Topics: Animals; Antigens, Neoplasm; Cancer Vaccines; CD8-Positive T-Lymphocytes; Cells, Cultured; Cytotoxicity, Immunologic; Drug Carriers; Interferon-gamma; Intramolecular Oxidoreductases; Lactic Acid; Lipid A; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Nanoparticles; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Toll-Like Receptor 4 | 2008 |
Immunomodulatory and anticancer effects of intra-tumoral co-delivery of synthetic lipid A adjuvant and STAT3 inhibitor, JSI-124.
Topics: Adjuvants, Immunologic; Animals; Antineoplastic Combined Chemotherapy Protocols; Dendritic Cells; Drug Delivery Systems; Glycolates; Immune Tolerance; Injections, Intralesional; Lactic Acid; Lipid A; Male; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Nanoparticles; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; STAT3 Transcription Factor; T-Lymphocytes, Regulatory; Triterpenes | 2009 |
In vivo evidence of oral vaccination with PLGA nanoparticles containing the immunostimulant monophosphoryl lipid A.
Topics: Adjuvants, Immunologic; Animals; Enzyme-Linked Immunosorbent Assay; Lactic Acid; Lipid A; Mice; Mice, Inbred BALB C; Microscopy, Electron, Scanning; Nanoparticles; Ovalbumin; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Vaccination | 2011 |
Robust IgG responses to nanograms of antigen using a biomimetic lipid-coated particle vaccine.
Topics: Adjuvants, Immunologic; Animals; Antigens; Biomimetics; Cells, Cultured; Dendritic Cells; Female; Galactosylceramides; Immunoglobulin G; Lactic Acid; Lipid A; Lipids; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Transgenic; Nanoparticles; Ovalbumin; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; T-Lymphocytes; Vaccines, Subunit | 2012 |
Quantitation of the immunological adjuvants, monophosphoryl lipid A and Quil A in poly (lactic-co-glycolic acid) nanoparticles using high performance liquid chromatography with evaporative light scattering detection.
Topics: Adjuvants, Immunologic; Chromatography, High Pressure Liquid; Drug Liberation; Lactic Acid; Limit of Detection; Lipid A; Nanoparticles; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Quillaja Saponins | 2015 |
Development and Evaluation of Biodegradable Particles Coloaded With Antigen and the Toll-Like Receptor Agonist, Pentaerythritol Lipid A, as a Cancer Vaccine.
Topics: Adjuvants, Immunologic; Animals; Antigens; Biocompatible Materials; Cancer Vaccines; Chemistry, Pharmaceutical; Cytokines; Dendritic Cells; Female; Lactic Acid; Lipid A; Mice; Mice, Inbred C57BL; Neoplasms; Ovalbumin; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Propylene Glycols; Toll-Like Receptors | 2016 |
In Vitro Evaluation of the Biological Responses of Canine Macrophages Challenged with PLGA Nanoparticles Containing Monophosphoryl Lipid A.
Topics: Adjuvants, Immunologic; Animals; Biological Transport; Cell Survival; Dogs; Drug Carriers; Drug Compounding; Female; Gene Expression; Histocompatibility Antigens Class I; Histocompatibility Antigens Class II; Interleukin-10; Interleukin-12 Subunit p40; Lactic Acid; Lipid A; Macrophages; Male; Ovalbumin; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Primary Cell Culture; Trypan Blue; Tumor Necrosis Factor-alpha | 2016 |
Design and immunological evaluation of anti-CD205-tailored PLGA-based nanoparticulate cancer vaccine.
Topics: Adjuvants, Immunologic; Animals; Antibodies, Monoclonal; Antigens, CD; Cancer Vaccines; Cell Line; Coumarins; Cytokines; Dendritic Cells; Immunotherapy; Lactic Acid; Lectins, C-Type; Lipid A; Mice; Minor Histocompatibility Antigens; Nanoparticles; Ovalbumin; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Receptors, Cell Surface; T-Lymphocytes | 2018 |